Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
NCT00118664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2016-06-14
Summary
The purpose of this study is to learn how blood clotting substances respond in children with septic shock, low platelet counts, and multiple organ failure (MOF) treated at different institutions.
Multiple organ failure can be related to an infection producing "septic shock," in which substances released in the blood cause poor blood flow to the organs. The number of platelets circulating in your child's blood stream is also decreased (this is called "thrombocytopenia") as a result of this condition. Research has shown that certain substances in the part of the blood known as plasma (the clear liquid part of the blood not including the red blood cells but holding blood clotting factors) can cause the organs to work poorly. The investigators would like to compare these blood responses in children with this condition, receiving a variety of different treatments, for multiple organ failure in other medical centers around the world. The investigators hope to enroll 80 patients into the study.
Conditions
- Septic Shock
- Thrombocytopenia
- Multiple Organ Failure
Sponsors & Collaborators
-
Children's Healthcare of Atlanta
lead OTHER
Principal Investigators
-
James D. Fortenberry, MD · Children's Healthcare of Atlanta
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis
NCT03388944 ·Status: COMPLETED ·Phase: NA
-
Study of Platelet Activation in Septic Shock Patients
NCT02635854 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
NCT00005890 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Plasmaexchange in Early Septic Shock
NCT04231994 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock
NCT01352182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
NCT00034476 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)
NCT02567305 ·Status: UNKNOWN
-
Life After Pediatric Sepsis Evaluation
NCT01415180 ·Status: COMPLETED
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048 ·Status: RECRUITING
-
A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock
NCT01145560 ·Status: COMPLETED ·Phase: PHASE2
-
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
NCT05692128 ·Status: UNKNOWN
-
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126 ·Status: COMPLETED
-
Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study
NCT00732277 ·Status: COMPLETED ·Phase: PHASE2
-
Sepsis-associated Thrombocytopenia and Platelet Transfusion (STAPT)
NCT07230067 ·Status: RECRUITING
-
Plasmaexchange in Early Septic Shock
NCT03065751 ·Status: UNKNOWN ·Phase: NA
-
Milrinone Versus Placebo in Patients With Septic Shock
NCT05122884 ·Status: UNKNOWN ·Phase: PHASE2
-
Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis
NCT06657781 ·Status: RECRUITING
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
Study the Impact of Statins in Septic Shock
NCT02681653 ·Status: COMPLETED ·Phase: NA
-
Platelet Transfusion in Sepsis Trial
NCT03968484 ·Status: WITHDRAWN ·Phase: NA
-
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
NCT00430859 ·Status: COMPLETED ·Phase: PHASE2
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study
NCT04580563 ·Status: COMPLETED ·Phase: NA